Deutsche Bank Upgrades BioNTech to Buy, Maintains Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank has upgraded BioNTech (NASDAQ:BNTX) from Hold to Buy, maintaining the price target at $95.
August 07, 2024 | 9:16 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank has upgraded BioNTech from Hold to Buy, maintaining the price target at $95. This upgrade could positively impact BioNTech's stock price in the short term.
An upgrade from a major financial institution like Deutsche Bank typically signals confidence in the company's future performance, which can attract more investors and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100